Cargando…
Severe hyperglycemia and insulin resistance in patients with SARS-CoV-2 infection: a report of two cases
BACKGROUND: Severe insulin resistance is an uncommon finding in patients with type 2 diabetes but is often associated with difficult to managing blood glucose. While severe insulin resistance is most frequently seen in the setting of medication side effects or rare genetic conditions, this report of...
Autores principales: | Affinati, Alison H., Wallia, Amisha, Gianchandani, Roma Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123093/ https://www.ncbi.nlm.nih.gov/pubmed/33992101 http://dx.doi.org/10.1186/s40842-021-00121-y |
Ejemplares similares
-
Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2
por: Reiterer, Moritz, et al.
Publicado: (2021) -
Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2
por: Reiterer, Moritz, et al.
Publicado: (2021) -
Caring for Hospitalized Patients with Diabetes Mellitus, Hyperglycemia, and COVID-19: Bridging the Remaining Knowledge Gaps
por: Wallia, Amisha, et al.
Publicado: (2020) -
Hyperglycemia in the Posttransplant Period: NODAT vs Posttransplant Diabetes Mellitus
por: Gupta, Suruchi, et al.
Publicado: (2018) -
Seroprevalence and Correlates of SARS-CoV-2 Antibodies in Health Care Workers in Chicago
por: Wilkins, John T, et al.
Publicado: (2020)